Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
McMaster chemists and neurobiologists team up to tackle cancer that spreads to the brain
Researchers at McMaster University have identified a new therapeutic approach to preventing cancer from spreading to the brain. In a new study, published recently in . . .
Researchers discover reason for disrupted DNA repair in Huntington’s disease patients
The protein that mutates in patients with Huntington’s disease can’t repair DNA as intended, impacting the ability of brain cells to heal themselves, McMaster researchers . . .
Heart & Stroke awards $5M to McMaster project aimed at reducing heart conditions in pregnancy
A project led by McMaster University focused on creating a better understanding of risk factors for heart conditions during pregnancy has been awarded $5 million . . .
Discover how Our Research is making an Impact
